RaySearch founder Johan Löf nominated for global entrepreneurship award

The winner of EY World Entrepreneur Of The Year, the premier international award for entrepreneurs, will be announced On 10 June. The finalist representing Sweden is Johan Löf, CEO and founder of RaySearch Laboratories AB, which develops innovative software that improves cancer treatment for millions of patients worldwide. Löf will compete against entrepreneurs from over 60 countries.

EY Entrepreneur Of The Year celebrates successful entrepreneurs who stimulate economic growth. An independent national jury selected Löf as Sweden's representative in the international final, highlighting, achievements such as his founding of a company that benefits both individuals and society.

The competition takes place in Monaco on 7-11 June. An independent international jury will name the winner on the evening of 10 June. Finalists are judged on six criteria: entrepreneurial spirit, economic development, strategic direction, impact on the wider world, innovation, and personal integrity and impact.

When Johan Löf was 16, his mother died of lung cancer. Her death had a strong impact on his career choice. He founded RaySearch in 2000, based on discoveries he made during his PhD work at Karolinska Institutet in Sweden, and the company was listed in 2003. RaySearch’s main product today is RayStation®, an innovative system that enables cancer clinics to plan the optimal treatment approach for each patient. RayStation is used by over 400 cancer clinics around the world. RaySearch currently has around 220 employees, of whom 120 work with research and development.

Carlos Esterling, who is responsible for EY Entrepreneur Of The Year in Sweden, said: “Johan Löf is the very image of an innovative entrepreneur. His amazing drive and exemplary leadership have led to great advances in cancer treatment both in Sweden and internationally. We at EY believe that entrepreneurs are essential for Sweden’s future, and our award recognizes role models who inspire others with the courage to pursue their ideas. I am proud that Johan will represent Sweden's outstanding entrepreneurship. His business is a world leader, and I believe he has an excellent chance in the final.”

Johan Löf, CEO and founder of RaySearch, said: “It is a great honor to represent Sweden in the global final of this entrepreneurship award. I look forward to competing with my product, which improves quality of life for millions of patients. Being an entrepreneur means constantly creating new opportunities, and continued expansion is on the agenda for RaySearch. I am also extremely excited about this opportunity to meet entrepreneurs from all over the world.”

About EY Entrepreneur Of The Year
EY Entrepreneur Of The Year is one of the world's top awards for entrepreneurs. The competition started in the United States in 1986 and was introduced to Sweden in 1995. It is the first international award for entrepreneurs who build successful companies based on clear vision and strong leadership skills. The competition is run at regional, national and international levels in more than 140 cities and 60 countries. An independent jury assesses entrepreneurs according to the following criteria: entrepreneurial spirit, economic development, strategic direction, impact on the wider world, innovation, and personal integrity and influence.
More information about the award, the program and the finalists: www.ey.com/weoy
For video material, please visit the newsroom: https://broadcast.ey.com

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit  ey.com .

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003.

More information about RaySearch is available at www.raysearchlabs.com

* Subject to regulatory clearance in some markets.

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Carlos Esterling, Responsible for EY Entrepreneur Of The Year Sweden
Telephone: +46 (0)70-3189197
carlos.esterling@se.ey.com

Stina Gustafsson, PR Manager EY Sverige
Telephone: +46 (0)73-355061
stina.gustafsson@se.ey.com 

About Us

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.

Subscribe

Media

Media